KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Alnylam Pharmaceuticals (ALNY) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Alnylam Pharmaceuticals (ALNY) over the last 8 years, with Q3 2025 value amounting to 0.03.

  • Alnylam Pharmaceuticals' Debt Ratio changed N/A to 0.03 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.03, marking a year-over-year change of. This contributed to the annual value of 0.02 for FY2024, which is N/A changed from last year.
  • Alnylam Pharmaceuticals' Debt Ratio amounted to 0.03 in Q3 2025.
  • Alnylam Pharmaceuticals' Debt Ratio's 5-year high stood at 0.19 during Q4 2021, with a 5-year trough of 0.02 in Q4 2024.
  • Its 3-year average for Debt Ratio is 0.06, with a median of 0.03 in 2025.
  • The largest annual percentage gain for Alnylam Pharmaceuticals' Debt Ratio in the last 5 years was 23034.78% (2021), contrasted with its biggest fall of 23034.78% (2021).
  • Quarter analysis of 3 years shows Alnylam Pharmaceuticals' Debt Ratio stood at 0.19 in 2021, then tumbled by 88.07% to 0.02 in 2024, then grew by 13.01% to 0.03 in 2025.
  • Its last three reported values are 0.03 in Q3 2025, 0.03 for Q2 2025, and 0.03 during Q1 2025.